5 Results for "

bladder muscle contractility

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "bladder muscle contractility" in MCE Product Catalog:

Cat. No.: HY-14825A
CAS No.: 1159101-48-0
Purity:  99.86%
Synonyms: SVT-40776 D-tartrate
Target:  

mAChR

Research Areas:  

Inflammation/Immunology

Tarafenacin (SVT-40776) D-tartrate is an orally active, selective M3 muscarinic receptor (M3 muscarinic receptor) antagonist with 203-fold selectivity over the M2 muscarinic receptor. Tarafenacin D-tartrate does not affect atrial contraction, arterial blood pressure or arterial pressure at high doses. Tarafenacin D-tartrate can be used in the research of overactive bladder .
loading...
    loading...
Cat. No.: HY-117717
CAS No.: 144730-93-8
Research Areas:  

Others

(Rac)-SC-31391, a prostaglandin analog, is a strong activator of the bladder muscle contractility that enhanced twitch responses elicited by field stimulation in the guinea pig detrusor muscle. (Rac)-SC-31391 contracts human bladder muscle through the activation of PGF receptors .
loading...
    loading...
Cat. No.: HY-14825
CAS No.: 385367-47-5
Synonyms: SVT-40776
Target:  

mAChR

Research Areas:  

Inflammation/Immunology

Tarafenacin (SVT-40776) is an orally active, selective M3 muscarinic receptor (M3 muscarinic receptor) antagonist with 203-fold selectivity over the M2 muscarinic receptor. Tarafenacin does not affect atrial contraction, arterial blood pressure or arterial pressure at high doses. Tarafenacin can be used in the research of overactive bladder .
loading...
    loading...
Cat. No.: HY-19185
CAS No.: 147696-46-6
Target:  

Potassium Channel

Research Areas:  

Endocrinology

ZD-2767 is a selective ATP-sensitive potassium channel agonist. ZD-276 reduces cell membrane excitability and contractility by activating KATP channels in bladder smooth muscle. ZD-2767 is promising for research of overactive bladder .
loading...
    loading...
Cat. No.: HY-182599
CAS No.: 129927-37-3
Target:  

Calcium Channel mAChR

Research Areas:  

Neurological Disease

RCC-36 hydrochloride is an L-type calcium channel inhibitor and competitive muscarinic receptor antagonist. RCC-36 hydrochloride inhibits L-type calcium currents in voltage- and concentration-dependent fashion with no effect on cardiac K + currents. RCC-36 hydrochloride suppresses maximum acetylcholine-induced contractile responses, inhibits detrusor muscle contractions induced by potassium chloride, calcium chloride, and electric field stimulation, including atropine-resistant contractions. RCC-36 hydrochloride can be used for the research of urinary frequency, urinary incontinence, and bladder overactivity .
loading...
    loading...